Valneva SE (EPA:VLA)
France · Delayed Price · Currency is EUR 3.720
+0.062 (1.69%)
At close: Nov 10, 2025
Valneva SE Market Cap
Valneva SE has a market cap or net worth of €628.19 million as of November 10, 2025. Its market cap has increased by 45.12% in one year.
Market Cap
628.19M
Enterprise Value
663.81M
Revenue
196.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.72
Market Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 99.08M to 628.19M, an increase of 534.03%. That is a compound annual growth rate of 10.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 628.19M | 78.92% |
| Dec 31, 2024 | 351.10M | -46.40% |
| Dec 29, 2023 | 655.08M | -23.93% |
| Dec 30, 2022 | 861.12M | -66.55% |
| Dec 31, 2021 | 2.57B | 265.20% |
| Dec 31, 2020 | 704.92M | 201.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.22B |
| Sanofi | 103.96B |
| Sartorius Stedim Biotech | 18.34B |
| bioMérieux | 12.59B |
| Eurofins Scientific SE | 10.34B |
| Ipsen | 10.18B |
| ABIVAX Société Anonyme | 6.68B |
| Virbac | 2.89B |